EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Clinical Spectrum, Heteroplasmy‐Phenotype Correlation, and Prognosis of the MT‐ND3 m.10191 T > C Mutation

Zimeng He iD, Huafang Jiang, Tongyue Li iD, Yang Liu, Ying Zou, Chaolong Xu, Zhimei Liu, Danmin Shen, Ruoyu Duan, Minhan Song iD, Yunxi Zhang, Zixuan Zhang und 4 weitere

CNS Neuroscience & Therapeutics · 2026-06 · 32 (6)

DOI: 10.1002/cns.70997 ↗

Kurz gefasst

Fachartikel in der Zeitschrift CNS Neuroscience & Therapeutics, online erschienen am 19.06.2026. Verfasst von Zimeng He und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China. Hauptthemen laut MEDLINE: Mutation, Leigh Disease, MELAS Syndrome, Electron Transport Complex I. Die Arbeit nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Beijing Municipal Science & Technology Commission, Administrative Commission of Zhongguancun Science Park, Science and Technology Developmental Project of Weifang.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

To systematically characterize the phenotypic spectrum, neuroimaging features, heteroplasmy‐phenotype correlation, and prognosis of the m.10191 T > C mutation.

Methods

We collected and analyzed data from 52 patients (14 newly recruited; 38 from literature). Phenotypes were pre‐classified as Leigh syndrome (LS), Leigh‐like syndrome (LLS), MELAS/LS overlap syndrome, and MELAS‐like syndrome. Neuroimaging data were subjected to statistical analysis to explore inter‐lesional associations and lesion‐symptom correlations. Heteroplasmy level underwent k‐means clustering and latent class analysis (LCA) to define data‐driven subgroups and model genotype–phenotype correlations. Prognostic factors were evaluated through Bayesian logistic regression, and survival analysis was conducted.

Results

The cohort exhibited phenotypic heterogeneity, dominated by LS (46.2%). Key features included epilepsy, developmental delay, and dystonia. Globus pallidus involvement frequently co‐occurred with midbrain and pontine lesions. Heteroplasmy level differed significantly across phenotypes. LCA identified three classes corresponding to clinical phenotypes. High heteroplasmy level, medullary involvement, and severe hyperlactatemia were associated with disease progression. Survival analysis indicated a 5 year survival rate of 80.0%, with high heteroplasmy level, hypotonia, and cerebellar lesions predicting poorer survival.

Interpretation

The m.10191 T > C mutation is linked to a continuous clinical spectrum correlated with heteroplasmy level. Specific clinical and neuroimaging features serve as valuable biomarkers for phenotypic classification and prognostic assessment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MutationLeigh DiseaseMELAS SyndromeElectron Transport Complex IHumansPhenotypeFemalePrognosisMaleGenetic Association StudiesChild, PreschoolChildCohort Studies

Stichwörter der Autor:innen

MT‐ND3complex I deficiencyleigh syndromem.10191 T > Cmitochondrial encephalomyopathy with lactate acidosis and stroke‐like episodes…

Substanzen

Electron Transport Complex I

Autor:innen und Institutionen

  • Department of Neurology, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China.
  • Department of Pediatrics, Weifang Maternal and Child Health Hospital, Weifang, Shandong, China.
  • Department of Genetics, Children's Hospital of Fudan University, Shanghai, China.

ORCID-Profile: Zimeng He, Tongyue Li, Minhan Song, Fang Fang

Förderung

  • National Natural Science Foundation of China
  • Beijing Municipal Science & Technology Commission, Administrative Commission of Zhongguancun Science Park
  • Science and Technology Developmental Project of Weifang
  • Beijing Municipal Science and Technology Commission, Adminitrative Commission of Zhongguancun Science Park

Zitieren

APA

He, Z., Jiang, H., Li, T., Liu, Y., Zou, Y., Xu, C., Liu, Z., Shen, D., Duan, R., Song, M., Zhang, Y., Zhang, Z., Sun, M., Shen, R., Xue, H., & Fang, F. (2026). Clinical Spectrum, Heteroplasmy‐Phenotype Correlation, and Prognosis of the MT‐ND3 m.10191 T > C Mutation. CNS Neuroscience & Therapeutics, 32(6). https://doi.org/10.1002/cns.70997

Vancouver

He Z, Jiang H, Li T, Liu Y, Zou Y, Xu C, et al. Clinical Spectrum, Heteroplasmy‐Phenotype Correlation, and Prognosis of the MT‐ND3 m.10191 T > C Mutation. CNS Neuroscience & Therapeutics. 2026;32(6). doi:10.1002/cns.70997

BibTeX
@article{He2026,
  author = {He, Zimeng and Jiang, Huafang and Li, Tongyue and Liu, Yang and Zou, Ying and Xu, Chaolong and Liu, Zhimei and Shen, Danmin and Duan, Ruoyu and Song, Minhan and Zhang, Yunxi and Zhang, Zixuan and Sun, Mingxi and Shen, Rui and Xue, Hong and Fang, Fang},
  title = {Clinical Spectrum, Heteroplasmy‐Phenotype Correlation, and Prognosis of the MT‐ND3 m.10191 T > C Mutation},
  journal = {CNS Neuroscience & Therapeutics},
  year = {2026},
  volume = {32},
  number = {6},
  doi = {10.1002/cns.70997}
}
Kostenlos starten →